Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Caribou Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CRBU
Nasdaq
8731
https://www.cariboubio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Caribou Biosciences Inc
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
- Apr 15th, 2024 1:00 pm
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
- Apr 4th, 2024 8:00 pm
With 65% institutional ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst the big guns
- Apr 1st, 2024 10:18 am
All You Need to Know About Caribou Biosciences, Inc. (CRBU) Rating Upgrade to Buy
- Mar 14th, 2024 4:00 pm
11 Oversold NASDAQ Stocks To Buy Right Now
- Mar 13th, 2024 7:32 pm
Why Caribou Biosciences Stock Is Crashing Today
- Mar 12th, 2024 4:37 pm
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Mar 11th, 2024 8:05 pm
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
- Mar 5th, 2024 9:30 pm
12 $10 Stocks That Will Triple
- Feb 26th, 2024 6:14 pm
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
- Feb 26th, 2024 11:45 am
Steven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfolio
- Feb 24th, 2024 4:25 am
Caribou Biosciences to Participate in Upcoming Investor Conferences
- Feb 15th, 2024 9:05 pm
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare
- Feb 12th, 2024 1:30 pm
Caribou Biosciences (NASDAQ:CRBU) Is In A Good Position To Deliver On Growth Plans
- Feb 7th, 2024 1:06 pm
3 Biotech Stocks You Can Buy and Hold for the Next Decade
- Jan 15th, 2024 1:45 pm
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
- Jan 7th, 2024 4:00 pm
3 Gene-Editing Stocks With the Potential to Mint Millionaires
- Dec 13th, 2023 10:20 am
Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024
- Dec 12th, 2023 9:02 pm
Caribou Biosciences, Inc. (CRBU) Upgraded to Buy: What Does It Mean for the Stock?
- Dec 8th, 2023 5:00 pm
Wall Street Analysts Believe Caribou Biosciences, Inc. (CRBU) Could Rally 285.29%: Here's is How to Trade
- Dec 6th, 2023 2:55 pm
Scroll